Evidence map›Paper›PMID 30279500›Full record

ArticleScientific reports2018

The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers.

Rhonda J Staversky, Daniel K Byun, Mary A Georger, Brandon J Zaffuto, Alexandra Goodman, Michael W Becker, Laura M Calvi, Benjamin J Frisch

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. CCR5 marks a subset of mouse hematopoietic stem cells that are myeloid primed and expand with age.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Development of anMolecular therapy. Methods & clinical development · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Identification and functional characterization of CD133Molecular and cellular biochemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rhonda J StaverskyDepartment of Medicine Hematology/Oncology Division University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Daniel K ByunDepartment of Medicine Hematology/Oncology Division University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Mary A GeorgerDepartment of Medicine Endocrine Division University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Brandon J ZaffutoDepartment of Medicine Endocrine Division University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Alexandra GoodmanDepartment of Medicine Hematology/Oncology Division University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Michael W BeckerDepartment of Medicine Hematology/Oncology Division University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Laura M CalviDepartment of Medicine Hematology/Oncology Division University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Benjamin J FrischDepartment of Medicine Hematology/Oncology Division University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. benjamin_frisch2@urmc.rochester.edu.
University of Rochester · US

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR002001 · NCATS · UNIVERSITY OF ROCHESTER · PI WILSON, KAREN M., ZAND, MARTIN S · 2016 to 2024
$34.6M
The University of Rochester's Clinical and Translational Science InstituteUL1TR000042 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$14.4M
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
The University of Rochester Core Center for Musculoskeletal Biology and MedicineP30AR061307 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCHWARZ, EDWARD M. · 2011 to 2015
$3.0M
Therapeutic Targeting of Leukemia-Microenvironmental InteractionsR01CA166280 · NCI · UNIVERSITY OF ROCHESTER · PI BECKER, MICHAEL W, CALVI, LAURA M · 2013 to 2017
$1.6M
Modulation of aged hematopoietic stem cell nichesR01AG046293 · NIA · UNIVERSITY OF ROCHESTER · PI BECKER, MICHAEL W, CALVI, LAURA M · 2013 to 2017
$954k
Molecular Mechanism of Osteoblastic Inhibition in Myeloid MalignanciesF32CA180615 · NCI · UNIVERSITY OF ROCHESTER · PI FRISCH, BENJAMIN JAMES · 2014 to 2016
$169k
NCATS NIH HHS UL1 TR000042NCATS NIH HHS UL1 TR002001NCI NIH HHS R01 CA166280NIAMS NIH HHS P30 AR069655NIA NIH HHS R01 AG046293U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA166280U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA180615U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR061307U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) AG046293
6 · The paper itself

Abstract

The chemokine CCL3 is frequently overexpressed in malignancies and overexpression leads to microenvironmental dysfunction. In murine models of chronic myelogenous leukemia (CML), CCL3 is critical for the maintenance of a leukemia stem cell population, and leukemia progression. With CCL3 implicated as a potentially viable therapeutic target, it is important to carefully characterize its role in normal hematopoietic homeostasis. CCL3

Indexed as

Cell DifferentiationAnimalsCell CountChemokine CCL3Hematopoietic Stem CellsMiceMice, KnockoutMyeloid CellsCcl3 protein, mouseChemokine CCL3

Identifiers

PMID30279500
PMCPMC6168534
OpenAlexW2893430359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.